Таблица 2. Система антиоксидантной защиты слюны при раке легкого различных гистологических типов.

Indicators

Control Group, n=215 (1)

АC, n=174 (2)

SCLC, n=116 (3)

Uric acid nmol/ml

104.76
[46.37; 178.90]

76.92
[34.62; 165.47]

99.77
[45.31; 167.05]

Albumin, mmol/l

0.298
[0.199; 0.484]

0.337
[0.183; 0.535]

0.315
[0.178; 0.495]

Catalase, mcat/l

4.85
[3.77; 6.11]

2.74
[2.05; 4.30]

2.70
[2.11; 3.83]

-

р1-2˂0.0001

р1-3˂0.0001

SOD, c.u.

63.16
[34.21; 105.26]

61.84
[23.68; 110.53]

56.58
[27.63; 90.79]

АОА, mmol/l

1.67
[1.41; 2.14]

1.77
[1.41; 2.10]

1.81
[1.60; 2.10]

Peroxidase, c.u.

0.415
[0.300; 0.790]

0.465
[0.360; 0.925]

0.430
[0.220; 0.630]

SOD/Catalase

13.02
[9.07; 17.23]

17.02
[9.04; 36.39]

21.95
[9.28; 40.22]

-

р1-2=0.0341

р1-3˂0.0001

SOD/ Peroxidase

152.2
[114.0; 193.7]

125.1
[29.6; 201.3]

97.0
[61.2; 224.4]

-

р1-2=0.0287

р1-3˂0.0001

Примечание. АК – аденокарцинома, ПРЛ – плоскоклеточный рак легкого.